London & the Continent

Two sides of the Euro coin

OXFORD - There can be little doubt that 1998 was another annus horribilis for the U.K. biotech sector, following a bad 1997. The sector was in the news for all the wrong reasons and this had a knock-on effect on confidence in the sector. What good news there was met with a muted response.

On the Continent, local trading by retail investors provided the sector with a greater sense of encouragement, which will be tested this year by the growing queue of companies wanting to float their shares.